PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 11, 2026Animal Models and Experimental MedicineOpen Access

Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection

View Full Paper
Ask AI
Bookmark
Share

Authors

ZLZifan LiYKYu KangYNYuyu Niu

Discussion

Loading...

Member takes

Overview

Randomized trial shows insulin independence in type 1 diabetes patients, highlighting promising therapeutic strategies.

Key Points

  • This research aims to evaluate the potential of stem cell-derived therapies for treating type 1 diabetes.
  • Utilized differentiation protocols to generate pancreatic β cells from pluripotent stem cells.
  • Conducted preclinical studies in mouse and nonhuman primate models.
  • Reviewed clinical trials assessing the safety and efficacy of stem cell-derived islets.
  • Transplantation of SC-islets resulted in remission of hyperglycemia in preclinical models.
  • A subset of patients with long-standing T1D achieved insulin independence, indicating a functional cure.
  • No serious adverse events of clinical significance were reported in early-phase clinical trials.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6a01726d3a9f334c28272908https://doi.org/10.1002/ame2.70211
View Full Paper
Ask AI
Bookmark
Share